Retinal gene therapy: The patient experience with Anna and Chelle May 27, 2026 Overview Show transcript Overview On the Mayo Clinic Ophthalmology Podcast, a patient and her mother discuss Leber congenital amaurosis and the first U.S. Food and Drug Administration (FDA)-approved retinal gene therapy. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleNovel surgical approach for retinal gene therapy shows promiseArticleNovel fibrin hydrogel gene therapy mitigates current treatment limitations for IRDs VID-20609756 Medical Professionals Retinal gene therapy: The patient experience with Anna and Chelle